In‐hospital management of persons with haemophilia and COVID‐19: practical guidance

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

A new disease (COVID‐19) caused by a coronavirus (SARS‐CoV‐2) that appeared in China at the end of 2019 is currently spreading globally. This emerging virus is mainly responsible for respiratory tract infections and potentially fatal pneumonia, mainly in more frail patients. Persons with haemophilia of variable severity and from all parts of the world will likely be infected and develop COVID‐19.

We here propose practical guidance for the in‐hospital specific management of haemophilia persons with COVID‐19 including their possible transfer to intensive care unit. Rapid identification of the haemophilia status, undelayed and regular liaison with the haemophilia team, proper therapy with factor concentrates or alternative treatments appear instrumental to prevent haemophilia‐related complications in this setting.

Information of patients and their families about COVID‐19, psychological support and good appreciation of the impact of haemophilia on therapeutic decisions including end of life directives are also addressed.

Related collections

Author and article information

Contributors

Cedric Hermans:

ORCID: https://orcid.org/0000-0001-5429-8437

cedric.hermans@uclouvain.be

Journal

Journal ID (nlm-ta): Haemophilia

Journal ID (iso-abbrev): Haemophilia

Journal ID (doi): 10.1111/(ISSN)1365-2516

Journal ID (publisher-id): HAE

Title: Haemophilia

Publisher: John Wiley and Sons Inc. (Hoboken )

ISSN (Print): 1351-8216

ISSN (Electronic): 1365-2516

Publication date (Electronic): 08 May 2020

Electronic Location Identifier: 10.1111/hae.14045

Affiliations

[ ¹ ] Haemostasis and Thrombosis Unit Division of Haematology Cliniques universitaires Saint‐Luc Université catholique de Louvain Brussels Belgium

[ ² ] Division of Intensive Care Cliniques universitaires Saint‐Luc Université catholique de Louvain Brussels Belgium

[ ³ ] Division of Infectious Diseases Department of Internal Medicine Cliniques universitaires Saint‐Luc Université catholique de Louvain Brussels Belgium

Author notes

[*] [* ] Correspondence

Cedric Hermans, MD, PhD, FRCP (Lon, Edin), Haemostasis and Thrombosis Unit, Division of Adult Haematology, St‐Luc University Hospital, Université catholique de Louvain (UCLouvain), Avenue Hippocrate 10 ‐ 1200 Brussels, BELGIUM

Email: cedric.hermans@ 123456uclouvain.be

Author information

Cedric Hermans https://orcid.org/0000-0001-5429-8437

Catherine Lambert https://orcid.org/0000-0003-2222-0357

Article

Publisher ID: HAE14045

DOI: 10.1111/hae.14045

PMC ID: 7272941

PubMed ID: 32384183

SO-VID: aa5ae71a-ad14-49a6-90c4-4c0d54a3c09a

License:

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

History

Page count

Figures: 0, Tables: 0, Pages: 14, Words: 227

Custom metadata

source-schema-version-number 2.0

edited-state accepted-manuscript

details-of-publishers-convertor Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.3 mode:remove_FC converted:05.06.2020

ScienceOpen disciplines: Hematology

Keywords: covid‐19,guidance,haemophilia,sars‐cov2

Data availability:

ScienceOpen disciplines: Hematology

Keywords: covid‐19, guidance, haemophilia, sars‐cov2

Comments

Comment on this article

scite_

Cited by 14

See all cited by

- Version 1